Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myeloma.

類似資料

• Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
  著者:: Croucher, P, 等
  出版事項: (2003)
• Osteoprotegerin and the development of myeloma bone disease
  著者:: Croucher, P, 等
  出版事項: (2004)
• Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
  著者:: Croucher, P, 等
  出版事項: (2001)
• Bone marrow endothelial cells produce osteoprotegerin: Evidence for a role in the development of myeloma bone disease
  著者:: De Leenheer, E, 等
  出版事項: (2004)
• Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
  著者:: Croucher, P, 等
  出版事項: (2001)